Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 14/20 | 0.52 |
| ▸ | CA2 | P00918 | 14/20 | 0.52 |
| ▸ | CA9 | Q16790 | 14/20 | 0.52 |
| ▸ | CA12 | O43570 | 6/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.49 |
| ▸ | ELF3 | P78545 | 4/20 | 0.48 |
| ▸ | MED23 | Q9ULK4 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13449584 | 1.00 | CA1 (0.52) | CA1CA2CA9CA12CA14 | |
| SCHEMBL15314740 | 0.80 | CA1 (0.63) | CA1CA2CA9CA12CA14 | |
| SCHEMBL17342554 | 0.80 | CA1 (0.63) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19961993 | 0.78 | CA1 (0.54) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13271743 | 0.77 | CA1 (0.52) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13097493 | 0.76 | CA9 (0.75) | CA1CA2CA9CA12CA14 | |
| SCHEMBL15828111 | 0.76 | CA9 (0.83) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19961511 | 0.75 | CA1 (0.57) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19962810 | 0.75 | CA1 (0.56) | CA1CA2CA9CA12CA14 | |
| SCHEMBL2234764 | 0.75 | CA9 (0.83) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120263649-A1 | DETECTION OF MYCOBACTERIA | ISIS INNOVATION LIMITED (GB) | 2012-10-18 | — | — | US | disclosed |
| WO-2011030160-A1 | DETECTION OF MYCOBACTERIA | ISIS INNOVATION LIMITED (GB) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120263649-A1 | DETECTION OF MYCOBACTERIA | LY96, MICA, CD74 | CA1 2576/4885CA2 1447/4885CA9 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.